Finalizing display...
Ligand source activities (1 row/activity)
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
α-MSH | 366 | None | 0 | Human | Binding | pKi | None | - | 8.20 | 3 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10358030 | |
α-MSH | 366 | None | 0 | Human | Binding | pKi | None | - | 8.20 | 3 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10493100 | |
γ-MSH | 1763 | None | 0 | Human | Binding | pKd | None | - | 8.50 | - | 1 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10358030 | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Binding | IC50 | = | 72.00 | 7.14 | 1 | 4 | Binding affinity for Human Melanocortin 3 receptor expressed in L-cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm000211e | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Binding | IC50 | = | 71.00 | 7.15 | 1 | 4 | Inhibition of [125I]NDP-MSH binding to Melanocortin 3 receptor expressed in HEK293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Binding | IC50 | = | 40.00 | 7.40 | 1 | 4 | Inhibition of [125I]NDP-MSH binding to Melanocortin 3 receptor expressed in HEK293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Binding | Ki | = | 690.00 | 6.16 | 1 | 4 | Binding affinity against human Melanocortin 3 receptor by gamma-MCH displacement. | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm030119t | |
ACTH | 277 | None | 0 | Human | Binding | pKi | = | - | 7.06 | -5 | 5 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/7774675 | |
ACTH | 277 | None | 0 | Human | Binding | pKi | = | 7.06 | 8.15 | -5 | 5 | None | Drug Central | - | - | - | - | - | - | - | |
ACTH-(4-10) | 218797 | 125I-NDP-MSH | 0 | Human | Binding | pKi | = | 784.00 | 6.11 | -7 | 4 | - | PDSP KiDatabase | 961.4 | 29 | 13 | 12 | -1.46 | CSCCC(N)C(=O)NC(CCC(=O)O)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O | - | |
ACTH-(4-10) | 218797 | 125I-[Nle4,D-Phe7]Alpha-MSH | 0 | Human | Binding | pKi | = | 784.00 | 6.11 | -7 | 4 | - | PDSP KiDatabase | 961.4 | 29 | 13 | 12 | -1.46 | CSCCC(N)C(=O)NC(CCC(=O)O)C(=O)NC(Cc1cnc[nH]1)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O | - | |
afamelanotide | 302 | None | 19 | Human | Binding | pKi | None | - | 8.90 | -2 | 8 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/10493100 | |
afamelanotide | 302 | None | 19 | Human | Binding | Ki | = | 0.68 | 9.17 | -2 | 8 | Binding affinity towards human Melanocortin 3 receptor (hMC3R) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/s0960-894x(03)00552-3 | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 1.17 | 8.93 | -2 | 8 | Displacement of [125I]NDP-MSH from Melanocortin 3 receptor at 10 uM | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm960840h | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 1.17 | 8.93 | -2 | 8 | Inhibitory concentration against human Melanocortin 3 receptor (hMC3R) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm960845e | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 3.30 | 8.48 | -2 | 8 | Inhibition of human Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm030111j | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 2.90 | 8.54 | -2 | 8 | Binding affinity for Human Melanocortin 3 receptor expressed in L-cells | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm000211e | |
afamelanotide | 302 | None | 19 | Human | Binding | EC50 | = | 0.13 | 9.89 | -2 | 8 | Effective concentration required for the biological activity against human Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm0303103 | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 3.80 | 8.42 | -2 | 8 | Inhibitory activity against Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm00018a005 | |
afamelanotide | 302 | None | 19 | Human | Binding | IC50 | = | 3.30 | 8.48 | -2 | 8 | Inhibition of [125I]NDP-MSH binding to Melanocortin 3 receptor expressed in HEK293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s |
Showing 1 to 20 of 1,138 entries
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
Ligands | Receptor | Activity | Chemical information | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common name | GPCRdb ID | Reference ligand | Vendors | Species | Assay Type | Activity Type | Activity Relation | Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description | Source | Mol weight | Rot Bonds | H don | H acc | LogP | Smiles | DOI | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Functional | pIC50 | = | - | 8.20 | 1 | 4 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/11150170 | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Functional | EC50 | = | 5.90 | 8.23 | 1 | 4 | Effective concentration required for intracellular cAMP accumulation against Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm000211e | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Functional | EC50 | = | 700.00 | 6.16 | 1 | 4 | Effective concentration for intracellular cAMP accumulation in human melanocortin 3 receptor expressing HEK 293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Functional | EC50 | = | 520.00 | 6.28 | 1 | 4 | Effective concentration for intracellular cAMP accumulation in human melanocortin 3 receptor expressing HEK 293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s | |
[D-Trp8]γ-MSH | 1501 | None | 4 | Human | Functional | EC50 | = | 3.70 | 8.43 | 1 | 4 | Intracellular cAMP accumulation in human Melanocortin 3 receptor functional assay. | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm030119t | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.36 | 9.44 | -15 | 8 | In vitro agonist potency was evaluated in HEK293 cells transfected with human melanocortin receptor (hMC3R) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1016/s0960-894x(03)00552-3 | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 4.10 | 8.39 | -15 | 8 | effective concentration of peptide at 50% maximal cAMP accumulation on Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm960840h | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 4.10 | 8.39 | -15 | 8 | Effective concentration that was able to generate 50% maximal intracellular cAMP in L-cells transfected with Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm960845e | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.80 | 9.10 | -15 | 8 | Effective concentration of peptide at 50% maximal cAMP generation | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm030111j | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.24 | 9.62 | -15 | 8 | Effective concentration required for intracellular cAMP accumulation against Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm000211e | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.13 | 9.88 | -15 | 8 | Evaluated for agonist activity at cloned Melanocortin 3 receptor | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm00018a005 | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.80 | 9.10 | -15 | 8 | Effective concentration for intracellular cAMP accumulation in human melanocortin 3 receptor expressing HEK 293 cells; (N = 4) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm049579s | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 6.80 | 8.17 | -15 | 8 | Agonist activity at EYFP-fused human MC3R expressed in HEK293 cells after 16 to 20 hrs by CRE-driven reporter assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.7b00353 | |
afamelanotide | 302 | None | 19 | Human | Functional | EC50 | = | 0.30 | 9.52 | -15 | 8 | Agonist activity at human MC3R expressed in HEK293 cells assessed as increase in cAMP production incubated for 2 hrs by AlphaScreen assay | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/acs.jmedchem.8b00251 | |
afamelanotide | 302 | None | 19 | Rat | Functional | EC50 | = | 0.10 | 10.00 | -1 | 8 | Maximal agonist response at rat melanocortin 3 receptor (MC3R) | ChEMBL | - | - | - | - | - | - | https://dx.doi.org/10.1021/jm030452x | |
agouti-related protein | 315 | None | 0 | Human | Functional | pIC50 | None | - | 7.70 | -39 | 3 | Unclassified | Guide to Pharmacology | - | - | - | - | - | - | https://pubmed.ncbi.nlm.nih.gov/9819197 | |
bremelanotide | 720 | None | 23 | Human | Functional | pEC50 | = | 8.62 | 8.06 | -5 | 4 | Agonist activity at human MC3R expressed in low doxycyclin-treated HEK293 cell membranes assessed as increase in cAMP production after 45 mins by HTRF method | Drug Central | - | - | - | - | - | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O | - | |
bremelanotide | 720 | None | 23 | Human | Functional | EC50 | = | 0.68 | 9.17 | -5 | 4 | Agonist activity at human MC3R expressed in HEK2936E cells assessed as cAMP production in presence of IBMX by time resolved fluorescence assay | ChEMBL | - | - | - | - | - | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.2c00793 | |
bremelanotide | 720 | None | 23 | Human | Functional | EC50 | = | 0.68 | 9.17 | -5 | 4 | Agonist activity at human melanocortin receptor 3 expressed in human T-REx-293 cells assessed as stimulation of intracellular cAMP accumulation incubated for 45 mins by LANCE cAMP assay | ChEMBL | - | - | - | - | - | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.1c00095 | |
bremelanotide | 720 | None | 23 | Human | Functional | EC50 | = | 2.40 | 8.62 | -5 | 4 | Agonist activity at human MC3R expressed in low doxycyclin-treated HEK293 cell membranes assessed as increase in cAMP production after 45 mins by HTRF method | ChEMBL | - | - | - | - | - | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O | https://dx.doi.org/10.1021/acs.jmedchem.8b00170 |
Showing 1 to 20 of 555 entries